U.S. Consumer Groups Oppose Teva’s Bid for Drug Rival Mylan

Groups call on U.S. regulator to oppose the merger on the grounds that it would lead to less competition and higher prizes of generic drugs.

Reuters
Send in e-mailSend in e-mail
A Teva employee works with sterile products during the manufacture of pharmaceuticals inside Teva's factory in Hungary.Credit: Bloomberg

Comments